UK pilot cataract surgery audit yields interesting findings

Article

A large survey has recently been piloted in the UK to demonstrate the use and benefits of electronic data collection with respect to rapidly monitoring the access, delivery and outcome of cataract surgery in the UK's National Health Service (NHS) and to update benchmark standards for these parameters of care.

A large survey has recently been piloted in the UK to demonstrate the use and benefits of electronic data collection with respect to rapidly monitoring the access, delivery and outcome of cataract surgery in the UK's National Health Service (NHS) and to update benchmark standards for these parameters of care.

Eight NHS departments that currently use specialty-specific electronic clinical systems or Electronic Patient Records (EPR) to collect a minimum preoperative, operative and anaesthetic data set for cataract surgery agreed to pool their data. Here is a round-up of some of the most important top line results presented.

  • An evaluation of the visual acuity threshold for cataract surgery found that it continues to fall in the UK and that the overall frequency of complications in modern surgery is low.


  • Nuclear/epinuclear fragment loss into the vitreous was found to be an uncommon complication.
  • Continuing collection of prospective data is feasible using the specialty-specific electronic clinical systems and could provide information useful to purchasers when planning healthcare priorities.


  • The systems used in the study led to the development of the 'Cataract National Dataset', which will be able to evaluate the process, delivery and outcome of cataract surgery in the NHS.


  • The survey demonstrated that electronic patient records (EPR) can ensure 100% operative data collection and update benchmark standards.


  • The EPR enabled identification of preoperative risk factors for posterior capsule rupture and vitreous loss through analysis of a large dataset. High risk cases could be predicted and allow surgeons to take appropriate precautions.


  • The study establishes a national benchmark for prediction error and demonstrated the potential of EPR to constantly monitor the quality of surgery in the NHS.


Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.